G. Sun

发表

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy

Jianyang Wang, Shulian Wang, J. Jin, 2020, Radiation oncology.

Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy

Jianyang Wang, Shulian Wang, J. Jin, 2020, BMC Cancer.

Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.

Chen Hu, Shulian Wang, J. Jin, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy

Shulian Wang, J. Jin, Ye-Xiong Li, 2021, Frontiers in Oncology.

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy

Jianyang Wang, Shulian Wang, J. Jin, 2020, Radiation Oncology.

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions

Jianyang Wang, Shulian Wang, J. Jin, 2020, BMC Cancer.

Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial.

Shulian Wang, J. Jin, Ye-Xiong Li, 2022, European journal of cancer.

Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes

Shulian Wang, Yu-jing Zhang, H. Fang, 2021, Breast.

Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial

Chen Hu, Shulian Wang, J. Jin, 2021, Frontiers in Oncology.

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.

Chen Hu, Shulian Wang, J. Jin, 2019, The Lancet. Oncology.

Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients with Breast Cancer: A Post-Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiotherapy.

Shulian Wang, J. Jin, H. Fang, 2020, International journal of radiation oncology, biology, physics.

Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy

Jianyang Wang, Shulian Wang, J. Jin, 2019, BMC Cancer.

Comparison of Treatment Outcomes With Breast‐conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score‐matched Analysis

Jianyang Wang, Shulian Wang, J. Jin, 2018, Clinical breast cancer.

Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions

Jianyang Wang, Shulian Wang, J. Jin, 2021, Frontiers in Oncology.

Radiotherapy plays an important role in improving the survival outcome in patients with T1–2N1M0 breast cancer – a joint analysis of 4262 real world cases from two institutions

Jianyang Wang, Shulian Wang, J. Jin, 2019, BMC Cancer.

Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective Analysis

Jianyang Wang, Shulian Wang, J. Jin, 2020, Frontiers in Oncology.

The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I–III triple-negative breast cancer

Bin Wang, Shulian Wang, H. Fang, 2023, British Journal of Cancer.

Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions

Jianyang Wang, Shulian Wang, J. Jin, 2022, Frontiers in Oncology.